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Abstract: The implementation of biocatalytic reactions in biotechnological processes requires enzymes with suitable properties. Thus, 
optimization of existing or identification of novel enzymes is needed. For enzyme optimization, various mutagenesis approaches are used 
yielding libraries with a large number of protein variants. Additionally, novel enzymes can be identified from metagenomic libraries, which 
contain bacterial clones expressing DNA isolated from different habitats. Activity-based screening of such libraries is needed to identify enzyme 
candidates of interest. Here, we provide a protocol for screening of regio- and enantioselective lipases stable under industrially relevant 
conditions. 
 




What Should be Considered During 
Planning Enzyme Screening Projects? 
CREENING methods for identification of enzymes with 
desired properties are important in biotechnology. 
These methods rely on the simultaneous analysis of a large 
number of samples defined as throughput, which can vary 
from medium (ca. 100-1000 samples), and high (104–105 
samples) to ultrahigh (>106 samples). Although screening 
methods can analyze only a small percentage of all 
theoretically possible enzyme variants, a number of 
successful screening projects for different enzyme classes 
were reported.[1–4] 
 The selection of a screening system with appropriate 
throughput depends on the number of enzyme variants to 
be tested. Screening methods with a (ultra)high throughput 
are mostly suitable for initial steps of screening. Even if 
these methods do not provide information about a desired 
property (e.g. stability or enantioselectivity), they may be 
very useful for pre-screening of bacterial clones producing 
an enzymatically active protein or carrying an expression 
plasmid with a correctly cloned gene of interest. Using the 
agar plate based “blue/white” selection system[5] one can 
easily distinguish those clones containing a gene of interest 
cloned into an expression vector from those containing the 
“empty” vector. This system is based on plasmids which 
encode part of the enzyme β-galactosidase, the so-called α-
peptide. The E. coli strains used to multiply these plasmids 
themselves encode the remaining part of β-galactosidase, 
the so-called ω-peptide. Only when both peptides are 
functionally expressed, enzymatically active β-
galactosidase is formed. In a molecular cloning experiment, 
the bacterial cells are grown in the presence of X-gal (5-
bromo-4-chloro-3-indolyl-β-D-galactopyranoside), a color-
less compound that can be hydrolyzed by β-galactosidase 
to form galactose and 5-bromo-4-chloro-3-hydroxyindole 
which dimerizes to form a blue indigo product. If plasmids 
have heterologous DNA inserted, no α-peptide is formed, 
i.e. functional β-galactosidase cannot be formed and the 
bacterial colonies remain white indicating successful 
cloning. If plasmids do not contain heterologous DNA, 
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indicating that insertion of heterologous DNA did not occur 
and thus the cloning has failed. Enzyme assays using agar 
plates containing a substrate for a target enzyme are 
routinely used to distinguish inactive from active variants.[6] 
These inexpensive methods may account for a significant 
reduction of screening effort and costs in a second 
screening round where positive clones are tested for a 
desired property. Colorimetric and fluorimetric assays are 
the methods of choice for detection of almost every 
enzyme property of interest using various 96- or 384-well 
microtiter plate (MTP). Opposite to MTP assays, 
throughput of chromatographic, NMR and mass 
spectroscopy techniques is smaller; therefore, they are 
considered as medium throughput methods. Nevertheless, 
throughput of these methods could be increased up to 
several thousand samples per day through parallelization 
and automation.[7,8] A powerful, highly sensitive and 
selective ultrahigh throughput method is called 
fluorescence activated cell sorting (FACS) and can directly 
(I.e. without the need for pre-screening) be used for 
screening. FACS methods rely on sorting of single cells 
which show fluorescence as the product of the activity of a 
target enzyme, as shown for the optimization of the 
enantioselectivity of esterase EstA from Pseudomonas 
aeruginosa.[9]  
 Beside throughput, three other parameters should 
carefully be considered before starting the screening 
project, namely (i) the signal-to-noise ratio, (ii) the cost 
factor and (iii) the relevance of screening results obtained 
with a surrogate substrate for the reaction when using the 
“real” substrate. 
 The reliability of screening results defines the signal-
to-noise ratio, which strongly depends on the used assay 
and biological system as they are affected by the presence 
of interfering compounds. Usually, screenings with growing 
microbial colonies (agar plate assays) and cells in FACS 
assays reveal more false positive clones than microtiter 
plate assays with crude cell lysates or culture supernatants. 
The main reasons for unreliable screening results are 
variations in protein expression levels among enzyme 
variants. 
 The importance of the screening results obtained 
with a surrogate substrate for later application with a real 
substrate of interest is to a large extent defined by the 
similarity of the chemical structures of the surrogate and 
real substrates. Hence, the substrate of interest should be 
used directly for screening whenever possible. Additionally, 
special care should be taken of the reaction conditions used 
for screening (surrogate conditions), which should mimic 
the conditions of the biocatalytic reaction as close as 
possible. The issue of surrogate parameters is best 
illustrated by Frances Arnold’s famous statement “you get 
what you screen for”.[10] Agar plate assays often allow 
usage of substrates identical to the “real” substrate of 
interest, but they do not provide flexibility in adjusting 
reaction conditions as the screening conditions must be 
favorable for bacterial growth. Recently, an activity-
independent screen based on processing of colonies grown 
on agar plates was developed allowing for the identification 
of protein variants with improved thermostability.[11] For 
FACS and MTP assays, a fluorescence or UV/VIS active 
functional group is attached to the surrogate substrate to 
allow easy handling of assays, but the results (e.g., 
enantioselectivity) may not necessarily be transferable to 
the biocatalytic conversion of “real” substrates. 
Do we still need New and Better 
Lipases? 
The application of lipases at an industrial scale was driven 
by the fact that these enzymes do not require costly 
cofactors for activity and are considerably stable at high 
temperatures as well as in organic solvents used in 
biotechnological processes.[12] However, most lipases lack 
selectivity for industrial substrates and optimal stability 
under harsh industrial process conditions; therefore, 
screening of large lipase libraries to identify a suitable 
catalyst is still required. Figure 1 shows the relation of assay 
parameters reliability, surrogate substrates, and 
throughput for different methods used for screening of 
lipase stability and enantioselectivity. For example, NMR 
and HPLC methods are suitable for screening of both, 
enantioselective and stable lipases, FACS methods are 
applicable for screening of lipase enantioselectivity while 
Quick E, pH shift, colorimetric and fluorimetric methods are 
best suitable for screening of lipase stability. 
 The physiological function of lipases is the hydrolysis 
of lipidic ester substrates although they catalyze the 
synthesis of esters under low water conditions, too.[12] 
Complete or partial substitution of water by an organic 
solvent not only shifts the thermodynamic equilibrium of a 
lipase reaction towards the product side, but also increases 
the solubility of hydrophobic substrates making them 
accessible for enzymatic conversions. Lipases, as well as 
most other enzymes, are not specific for one substrate, 
they naturally hydrolyze different substrates thus 
exhibiting “substrate promiscuity”.[13] These broad-range 
substrate acceptance of lipases and a good understanding 
of their catalytic mechanism from a large number of 3D 
structures,[14,15] biochemical and computational experi-
ments contributed to successful optimization of lipases 
towards selective biocatalysis of non-natural substrates. On 
the other hand, the relatively poor understanding of the 
underlying mechanisms of enzyme perturbation by 
temperature[16] and by chemical effectors, like organic 
solvents and detergents,[17] results in still large screening 
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 Lipases with novel features were and still are 
developed by some of the world’s largest enzyme 
producing biotech companies (e.g., Novozymes and 
BASF), and are utilized in various types of industries 
including detergent, dairy , feed supplement , chemical, 
cosmetic, and pharmaceutical industries.[18–20] 
Optimization of existing and discovery of novel lipases 
and their implementation in new industrial processes 
relying on the synergism with classical chemical reactions 
is an on-going process of high future relevance. Thus, 
recent advances in lipase-catalyzed production of 
biodiesel reveal their potential for helping to reduce 
dependence on fossil fuels.[21] Furthermore, latest reports 
of the capability of lipases to hydrolyze synthetic 
polymers used for plastic indicate their potential to fight 
global plastic pollution.[22] 
Screening for Regio- and 
Enantioselective Lipases 
Both hydrolytic and synthetic lipase reactions are used in 
organic chemistry mainly due to the regio- and 
enantioselectivity of lipases, e.g., for the regioselective 
 
Figure 1. Multiple parameters for various methods used for screening of lipases with increased stability (temperature, organic 
solvents or detergents) and enantioselectivity. With increasing value, the suitability of the method for screening of 
ennatioselectivity or stability is better. Higher values indicate better screening method parameters (surrogate substrate, 
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synthesis of sugar fatty acid esters or the enantioselective 
synthesis of psymberic acid by kinetic resolution.[2] 
However, substrate specific transformations require the 
identification of selective biocatalysts usually from large 
enzyme libraries. Therefore, MTP assays allowing for 
screening with label-free substrates (measurement of pH 
shift due to released carboxylic acids using indicators) or 
with labeled substrates (measurement of fluorescence or 
UV/VIS absorbance due to released fluorophore or 
chromophore, respectively) were developed.[2] We 
previously described the synthesis of para-nitrophenyl- (p-
NP, chromogenic) and 4-methylumbelliferyl- (fluorogenic) 
esters of a number of structurally differing and also 
industrially relevant substrates, for screening of regio- and 
enantioselective lipases. Screening of a mutant library of 
Serratia marcescens lipase (LipA) using p-nitrophenyl esters 
revealed two variants with increased specific activity 
towards (±)-3-(4′-methoxyphenyl)glycidic acid methyl 
ester, a key intermediate for the synthesis of diltiazem, a 
drug used for treatment of hypertension, angina pectoris, 
and arrhythmia.[23] These two examples clearly 
demonstrate the importance of chemical synthesis for the 
development of meaningful biological screens.[2]  
 We have characterized the regioselectivity of lipases 
from T. lanuginosus and B. cepacia using p-NP esters of 
fatty acids with different chain length, degree of branching, 
and arylic substituents.[24] Determining the rate of 
hydrolysis towards both enantiomers under non-
competitive conditions in separate reactions enables a fast 
estimation of the enantioselectivity of two tested 
lipases.[24] However, estimated and true 
enantioselectivities usually show discrepancies. To 
overcome this issue, Kazlauskas and coworkers developed 
the so-called Quick E method for the fast determination of 
the enantioselectivity of lipases under conditions 
simulating enantiomer competition.[25] It is based on the 
hydrolysis of a pure enantiomer of an (S)- or (R)-p-NP ester 
in the presence of a reference substrate (resorufine 
tetradecanoate) to ensure competition. The initial rates of 
hydrolysis of the (S)-enantiomer are determined at 404 nm 
and of the reference substrate at 572 nm in the same 
solution. After taking into account the initial concentrations 
of both substrates, the ratio of these hydrolysis rates yields 
the selectivity of the respective hydrolase for the (S)-
enantiomer over the reference compound. 
Screening of Lipases Stable in the 
Presence of Detergents 
Studies with lipases towards detergent tolerance were 
motivated by their usage in detergent formulations. 
Analyzing detergent tolerance also contributes to answer 
the basic question of how amphipathic molecules can 
destabilize proteins. For a systematic study of protein 
detergent tolerance we have selected the lipase LipA of 
Bacillus subtilis (BsLA). This enzyme, which shows 
biotechnological potential, is one of the smallest lipases 
known consisting of 182 amino acids; its structure and 
biochemical properties were intensively studied.[17] The 
gene encoding BsLA was subjected to a complete 
saturation mutagenesis by which each of its 181 naturally 
occurring amino acids was changed to all 19 remaining and 
naturally abundant amino acids yielding a library with all 
possible single amino acid exchanges. This BsLA library was 
obtained by Quikchange PCR using primer pairs containing 
the degenerated NNS codon (N=A/C/G/T, S=G/C) encoding 
all natural amino acids as well as the stop codon. All 3439 
clones of the library were sequenced thus confirming the 
completeness of the library. Clones expressing the lipase 
variants were cultivated for 16 h at 30 °C in microtiter 
plates using rich medium under conditions promoting 
secretion of the enzymes into the culture supernatant. This 
allowed analyzing the stability of the enzyme variants by 
measuring their activity with the substrate p-nitrophenyl 
butyrate after incubation of the supernatants with 
detergents, ionic liquids, organic solvents or at different 
temperatures. The comparison of enzyme activities of the 
variants with the wild-type BsLA resulted in the 
identification of mutations that destabilized the enzyme 
structures, enhanced its catalytic efficiency, or showed no 
effect at all. These results allowed for a detailed analysis of 
structure-function relationship of this model lipase. 
Additional studies using this BsLA library have provided 
unique insights into the role of single amino acids for 
different cellular processes, e.g. oxygen consumption, 
biomass formation, protein secretion and protein 
biosynthesis.[26,27]  
Conclusions 
Many different methods have been developed to identify 
novel lipases with appealing properties for industrial 
applications including high stability and 
enantioselectivity. As each of these methods shows its 
individual advantages and disadvantages, the choice of an 
appropriate system depends on the experimental 
requirements and available equipment. An impressive 
number of medium- and high-throughput methods are 
already available, and recent developments based on 
HPLC and GC may even further extended the throughput 
currently reachable. An impressive example comprises 
the simultaneous testing of 145 esterases isolated from 
metagenomic libraries against 96 chemically diverse 
esters. This study not only allowed to identify several 
promiscuous enzymes, but also added important insights 
by providing empirical, structural, computational data 
which facilitate the elucidation of the molecular basis of 
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